Winston-Salem, NC (PRWEB) August 07, 2014
PMG Research, Inc. announced today the election of its Board of Directors. Charles Hauser, CEO of Piedmont Stone Center, and John Vann, a business management consultant at The Summit Companies, will join Jennifer Byrne, Chairman of the Board and CEO of PMG Research, and Joel Lanik, Partner at Frontier Capital, as Directors on PMG Research Board.
PMG Research is a network of sites that provide clinical research services to pharmaceutical companies and CROs, with access to 1.7 million patient lives through its partnerships with large physician practices and integrated health systems. PMG Research is comprised of 10 hub site locations in the Southeastern United States and spans 53 physician practices.
“I am pleased to be a member of the PMG Research Board of Directors,” states Charles Hauser. “I look forward to the opportunity to continue to support PMG’s vision and drive for innovation within the clinical trials industry.” From 1980 to 2006, Mr. Hauser was the President and co-founder of Piedmont Medical Research Associates, now PMG Research. He has served on numerous corporate and community Boards, including the State Health Coordinating Council and the North Carolina Medical Care Commission.
John Vann has extensive experience in the clinical research industry, having co-founded Clinical Trial Management Services (CTMS) followed by several years in corporate development with a leading UK-based CRO. “I look forward to participating on the Board of PMG Research. PMG has a reputation for quality and experience, with a strong focus on patient engagement and strategic development that will help define the new landscape in clinical research,” explains Mr. Vann.
“We are grateful for the participation of Mr. H
Copyright©2014 Vocus, Inc.
All rights reserved